Cargando…
BST2, a Novel Inhibitory Receptor, Is Involved in NK Cell Cytotoxicity through Its Cytoplasmic Tail Domain
Bone Marrow Stromal Cell Antigen 2 (BST2) is a type II transmembrane protein expressed on various cell types that tethers the release of viruses. Natural killer (NK) cells express low levels of BST2 under normal conditions but exhibit increased expression of BST2 upon activation. In this study, we s...
Autores principales: | Oh, Jinsoo, Yi, Eunbi, Jeong, Soo Kyung, Park, Sehoon, Park, Se-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570199/ https://www.ncbi.nlm.nih.gov/pubmed/36232695 http://dx.doi.org/10.3390/ijms231911395 |
Ejemplares similares
-
MT1-MMP Inhibits the Activity of Bst-2 via Their Cytoplasmic Domains Dependent Interaction
por: Fan, Long, et al.
Publicado: (2016) -
Structural determinant of BST-2-mediated regulation of breast cancer cell motility: a role for cytoplasmic tail tyrosine residues
por: Naushad, Wasifa, et al.
Publicado: (2017) -
Epitope Tags beside the N-Terminal Cytoplasmic Tail of Human BST-2 Alter Its Intracellular Trafficking and HIV-1 Restriction
por: Lv, Mingyu, et al.
Publicado: (2014) -
HM1.24/BST-2 is constitutively poly-ubiquitinated at the N-terminal amino acid in the cytoplasmic domain
por: Fujimoto, Keiko, et al.
Publicado: (2020) -
Filamin A Is Required for NK Cell Cytotoxicity at the Expense of Cytokine Production via Synaptic Filamentous Actin Modulation
por: Kim, Nayoung, et al.
Publicado: (2022)